1. Home
  2. ICG vs INKT Comparison

ICG vs INKT Comparison

Compare ICG & INKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Intchains Group Limited

ICG

Intchains Group Limited

HOLD

Current Price

$0.84

Market Cap

49.4M

Sector

Technology

ML Signal

HOLD

Logo MiNK Therapeutics Inc.

INKT

MiNK Therapeutics Inc.

HOLD

Current Price

$10.69

Market Cap

52.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ICG
INKT
Founded
2017
2017
Country
China
United States
Employees
N/A
N/A
Industry
Semiconductors
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
49.4M
52.5M
IPO Year
2022
2021

Fundamental Metrics

Financial Performance
Metric
ICG
INKT
Price
$0.84
$10.69
Analyst Decision
Strong Buy
Buy
Analyst Count
2
2
Target Price
$5.25
$35.00
AVG Volume (30 Days)
91.3K
10.4K
Earning Date
05-21-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$6.80
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.60
$8.48
52 Week High
$3.06
$18.17

Technical Indicators

Market Signals
Indicator
ICG
INKT
Relative Strength Index (RSI) 51.48 47.11
Support Level $0.61 $10.72
Resistance Level $1.36 $12.61
Average True Range (ATR) 0.05 0.50
MACD 0.00 0.01
Stochastic Oscillator 55.56 37.23

Price Performance

Historical Comparison
ICG
INKT

About ICG Intchains Group Limited

Intchains Group Ltd is an inventive altcoins development company that engages in the provision of altcoin mining products, the strategic acquisition and holding of Ethereum-based cryptocurrencies and the active development of inventive Web3 applications. The company offers high-performance mining products including altcoin mining machines incorporating its ASIC chips that have high computing power and superior power efficiency, ASIC chips and ancillary software and hardware, all of which cater to the evolving needs of the blockchain industry. Geographically, it operates in Mainland China, Hong Kong, and Other countries or regions.

About INKT MiNK Therapeutics Inc.

MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development and manufacturing of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. iNKT cells offer distinct therapeutic advantages as a platform for allogeneic therapy in that the cells naturally home to tissues, aid clearance of tumors and infected cells, and suppress graft-versus-host-disease. Its product candidate, agenT-797, is an off-the-shelf, allogeneic, native iNKT cell therapy. It operates its business in single segment.

Share on Social Networks: